Additional file 7 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 7: Figure S7. The correlation analysis between the ICB expression and the risk scores

Additional file 10 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 10: Table S1 Top10 GO enrichment results

Additional file 9 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 9: Figure S9. Data source of TFs of the hub genes

Additional file 6 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 6: Figure S6. The expression of hub genes in L-02 hepatocyte cell and human HCC cells (Huh7)

Additional file 11 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 11: Table S2. qPCR primers used in this study

Additional file 4 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 4: Figure S4. Gene sequence binding site for hub genes-miRNA interaction

Additional file 8 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 8: Figure S8. The correlation analysis between the ICB expression and the risk scores

Additional file 5 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 5: Figure S5. Validtion analysis of hub genes. A Differential methylation positions (DMPs) identified in GSE174818. B The location of the DMPs relative to CpG islands in GSE174818. C The expression of hub genes in tumor tissue and normal tissues from GSE144269. D The expression of hub genes in tumor tissue and normal tissues from GSE214846

Additional file 1 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 1: Figure S1. Evaluation of the seven different kinds of immune cells in SARS-CoV-2 infection

Additional file 3 of Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets

Additional file 3: Figure S3. The expression of DNMT1, DNMT3A and DNMT3B in different risk group